BIA-Ceuticals is bringing a new line of cannabis based natural products with smart delivery system.
Our Team
Guy Landver
Chairman & CTO
Guy Landver is a pharmaceutical engineer, and the inventor of BIA's product line. Researcher of traditional medicine for over 25 years, and recently completed his latest research, at the Hebrew University, school of Pharmacy, into the molecular mechanism by which Cannabis and specifically Cannabidiol exhorts its therapeutic effects upon the central nervous system via Transient receptor potential Ankyrin 1, a newly identified receptor involved in the pain and inflammation pathway. Guy is responsible for primary product formulation, conducting the laboratory development phase, and overseeing the entire project.
Dr. Eitan Moore
VP R&D
Dr. Eitan Moore is a former head of R&D and VP Technologies at Intec Pharma-a drug delivery company. He has obtained his Ph.D. in Neuropharmacology from the University of Groningen in the Netherlands, did his post-doc at the School of Pharmacy of the Hebrew University and worked in Pharmaceutical companies in Israel and Europe and has many patents and scientific publications to his name. Eitan is responsible for the development of formulations, and production methods at BIA Ceuticals.
Tom Gross
VP Business Development
Tom Gross brings more than twenty years of experience in sales, marketing, operations and branding. Tom trained and led sales teams, managed and assisted the foundation of sales related companies in the fields of pharmaceuticals, tourism, and journalism. Over the last few years, he has been a sales and marketing strategy consultant to private companies, in Israel and abroad. Tom is responsible for business development, strategic financial planning, product marketing and sales. Tom studied piano performance at the Buchman-Mehta school of music in Tel aviv university, and has been teaching music theory and the art of piano playing over the past 20 years.
Our Team
Prof. Michael Friedman
Prof. Michael Friedman, will head the development of Drug Delivery Systems for our Products. He is a senior Professor at the Hebrew University, The school of Pharmacy, and recently appointed senior researcher at the newly established National Cannabinoids Research multidisciplinary Center. Michael has over 40 years’ experience in the area of drug delivery systems, with an added expertise in the field of herbal supplements and nutraceuticals.
Dr. Miriam Oron
Mingelgreen
Dr. Miriam Oron Mingelgreen, will head the regulatory and clinical trials division of the company. She is an expert in the fields of skincare, development of cosmetic products, European regulatory aspects, safety and compliance, formerly, head of product development at AHAVA, Dead Sea Laboratories. Miriam has over 25 years’ experience in the field and will be responsible for implementing and overseeing Clinical trials and regulatory matters.
Dr. Zakhar Nudelman
Dr. Zakhar Nudelman, will oversee the development of Products formulations. He has extensive experience in pharmaceutical industry, both running R&D and manufacturing, serving as advisor in the fields of pharmaceutics, biotech (pharma related), natural and cosmetic products. He will act as the main product development advisor at BIA.